Beatriz de la Cruz-Benito

7PUBLICATIONS
47CO-AUTHORS
NanomedicineMajor global burdens of diseaseRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 25, 2026
Real-world effectiveness and safety of Zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.

|Apr 03, 2021
Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia.

María-Teresa Álvarez Román, Víctor Jiménez Yuste, Sara García Barcenilla

|Dec 06, 2020
Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia.

Beatriz de la Cruz-Benito, María I Rivas-Pollmar, María T Álvarez Román

|Aug 08, 2020
Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak.

Beatriz de la Cruz-Benito, Paula Lázaro-Del Campo, Andrés Ramírez-López

Pageof 2

Frequent Collaborators

4 joint publications

Paula Lázaro-Del Campo

3 joint publications

Andrés Ramírez López

3 joint publications

Miguel Canales-Albendea

2 joint publications

Victor Jiménez Yuste